Synact Pharma
biotech company based in Sweden
Nasdaq Stockholm
ISIN SE0008241491 LEI 549300RRYIEFEQ72N546
Follow Synact Pharma
Weekly email: filings, results
Revenue, last year
SEK 0
Net income
−SEK 110.8M
−34.5% vs prior year
EPS, diluted
−SEK 2.17
−4.3% vs prior year
Operating cash flow
−SEK 97.3M
−9.1% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | SEK 0 | −SEK 110.8M |
| FY24 | SEK 0 | −SEK 82.4M |
| FY23 | SEK 0 | −SEK 215.8M |
| FY22 | SEK 0 | −SEK 99.2M |
| FY21 | SEK 0 | −SEK 69.3M |